Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03449927 · ClinicalTrials.gov registry record · Phase 1
Implementation of a Nutritional Tool During Melphalan Autologous Transplant to Improve Caloric and Protein Intake
A Phase 1 study of Melphalan Autologous Transplant, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03449927: Completed Phase 1 study of Melphalan Autologous Transplant, sponsored by Washington University School of Medicine.
NCT03449927 is a Phase 1 study of Melphalan Autologous Transplant that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03449927, a Phase 1 study of Melphalan Autologous Transplant, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot before and after interventional study is to determine if early intervention and provision of menus regarding appropriate diet choices for melphalan autologous transplant patients experiencing nausea and diarrhea will improve nutrition status and overall calorie and protein intake throughout the transplant process.
Conditions Studied
Interventions
- OTHER Specialized menu
- OTHER Standard of care menu
- OTHER Self report dietary intake worksheet
- OTHER Post study questionnaire
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2018-02-27 |
| Phase | Phase 1 |
What the finished NCT03449927 record still lists
NCT03449927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Melphalan Autologous Transplant appearing as the primary indexed condition, and to 4 interventions - of which Specialized menu is the first listed.
NCT03449927 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03449927 about?
NCT03449927 is a clinical study titled "Implementation of a Nutritional Tool During Melphalan Autologous Transplant to Improve Caloric and Protein Intake". The purpose of this pilot before and after interventional study is to determine if early intervention and provision of menus regarding appropriate diet choices for melphalan autologous transplant patients experiencing nausea and diarrhea will improve nutrition status and overall calorie and protein ...
What is the current status of trial NCT03449927?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2018-01-01. Estimated completion is 2018-02-27.
What conditions does trial NCT03449927 study?
This clinical trial studies the following conditions: Melphalan Autologous Transplant.
What interventions are being tested in trial NCT03449927?
The interventions under investigation include: Specialized menu (OTHER), Standard of care menu (OTHER), Self report dietary intake worksheet (OTHER), Post study questionnaire (OTHER).
Who is sponsoring clinical trial NCT03449927?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03449927 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03449927's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI